Αρχειοθήκη ιστολογίου

Σάββατο 9 Σεπτεμβρίου 2017

Osimertinib suitable for first line EGFRm lung cancer

Dr Ramalingam talks with ecancer at ESMO 2017 Congress in Madrid about the results of the double blind, randomised FLAURA trial, looking at the use of osimertinib versus the existing standard of care for patients with EGFR mutated lung cancer. He...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2xlrjy6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader